Floatz logo

Clofarabine

BAL

Nantes University HospitalSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the BAL cohort.

Asset / SponsorPhaseRating
Equine Atg
Nantes University Hospital
Phase 2B
Busulphan
Nantes University Hospital
Phase 2B

Same molecule, other indications

Clofarabine is also rated in:

acute myeloid leukemia with 11q23 abnormalitiesDormant
BB
Indicative ·
70 / 100
View asset →
acute myeloid leukemia, del(5q31-q32)Dormant
BB
Indicative ·
70 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →